Showing results (221-230 of 241) with videos related to

Sort By:
Pageof 25
Journal of Medical Genetics|March 20, 2016
Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry RegistryAlberto Ortiz, Ademola Abiose, Daniel G Bichet, et al.
Molecular Genetics and Metabolism|January 29, 2023
Clinical outcomes among young patients with Fabry disease who initiated agalsidase beta treatment before 30 years of age: An analysis from the Fabry RegistryRobert J Hopkin, Gustavo H Cabrera, John L Jefferies, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 10, 2020
A New Panel-Estimated GFR, Including β2-Microglobulin and β-Trace Protein and Not Including Race, Developed in a Diverse PopulationLesley A Inker, Sara J Couture, Hocine Tighiouart, et al.
Molecular Genetics and Metabolism|April 17, 2019
Low-dose agalsidase beta treatment in male pediatric patients with Fabry disease: A 5-year randomized controlled trialUma Ramaswami, Daniel G Bichet, Lorne A Clarke, et al.
Atherosclerosis|October 31, 2012
Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistanceSimonetta Bacci, Sabrina Prudente, Massimiliano Copetti, et al.
Diabetes|January 25, 2019
Genetic Determinants of Glycated Hemoglobin in Type 1 DiabetesAnna Syreeni, Niina Sandholm, Jingjing Cao, et al.
Pageof 25